Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06310200 · ClinicalTrials.gov registry record · Phase 1

Sphenopalatine Ganglion Block and Cold Induced Headaches

A Phase 1 study of Headache and Cold Induced Headache, sponsored by Wright State University.

Active
Registry status
Phase 1
Development phase
30
Enrollment target
1
Study location

NCT06310200 is a Phase 1 study of Headache and Cold Induced Headache that is active but no longer recruiting, run by Wright State University. The registered enrollment target is 30 participants, below the 155-participant average among 35 other Headache trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06310200, a Phase 1 study of Headache and Cold Induced Headache, is active but no longer recruiting, sponsored by Wright State University.

ACTIVE NOT RECRUITING
Registry status
Phase 1
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

The primary objective of this study is to determine if a sphenopalatine ganglion (SPG) block, performed through intranasal atomization of 4% lidocaine, is able to prevent cold induced cephalgia ("Brain Freeze"). Secondary objectives will be to determine the degree of decreased pain/duration of brain freeze after sphenopalatine ganglion block

Interventions

  • DRUG normal saline
  • DRUG Lidocaine Topical 4% Topical Solution
  • DRUG Bitrex

Study Locations (1)

Ohio

  • Wright state emergency medicine offices - Dayton

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2025-01-01
Est. Completion 2025-07-01
Phase Phase 1

Sponsor

Wright State University

32 total trials

What the Registry Record Tells You About NCT06310200

The ClinicalTrials.gov registry entry for NCT06310200 describes a study currently listed as active not recruiting, categorized as Phase 1. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 155-participant average among 35 other Headache trials with a reported enrollment target (81% lower). The listed sponsor is Wright State University, which has 32 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Headache appearing as the primary indexed condition, and to 3 interventions - of which normal saline is the first listed.

NCT06310200 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT06310200 about?

NCT06310200 is a clinical study titled "Sphenopalatine Ganglion Block and Cold Induced Headaches". The primary objective of this study is to determine if a sphenopalatine ganglion (SPG) block, performed through intranasal atomization of 4% lidocaine, is able to prevent cold induced cephalgia ("Brain Freeze"). Secondary objectives will be to determine the degree of decreased pain/duration of brain...

What is the current status of trial NCT06310200?

This trial is currently active not recruiting. It is a Phase 1 study. The enrollment target is 30 participants. The study started on 2025-01-01. Estimated completion is 2025-07-01.

What conditions does trial NCT06310200 study?

This clinical trial studies the following conditions: Headache, Cold Induced Headache, Brain Freeze, Cold Induced Cephalgia.

What interventions are being tested in trial NCT06310200?

The interventions under investigation include: normal saline (DRUG), Lidocaine Topical 4% Topical Solution (DRUG), Bitrex (DRUG).

Who is sponsoring clinical trial NCT06310200?

This trial is sponsored by Wright State University, which has 32 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06310200 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Headache

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.